Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

This publication has 29 references indexed in Scilit:

• Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
  JNCI Journal of the National Cancer Institute, 2009
• Etiologic Heterogeneity for Cervical Carcinoma by Histopathologic Type, Using Comparative Age-Period-Cohort Models
  Cancer Epidemiology, Biomarkers & Prevention, 2009
• Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
  Vaccine, 2008
• Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
  BMJ, 2008
• Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis
  American Journal of Epidemiology, 2008
• Age considerations when vaccinating against HPV
  Gynecologic Oncology, 2008
• Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
  Journal of Clinical Microbiology, 2006
• Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
  JNCI Journal of the National Cancer Institute, 2005
• The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based Study
  Gynecologic Oncology, 2000